CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

COVID-19 Vaccines and Allergic reactions

Life Sciences Review | Wednesday, February 10, 2021
Tweet

Boston health care worker who experienced reaction to Moderna coronavirus vaccine has a history of allergies.


FREMONT, CA: A health care worker who experienced an allergic reaction after receiving a Moderna Covid-19 vaccine at Boston Medical Center on Christmas Eve tells CNN he has a history of allergies.


This is the first known case of allergic reaction from a Moderna coronavirus vaccine, although there have been at least six similar reported cases in the United States associated with the Pfizer/BioNTech vaccine.


The employee received the Moderna vaccine Thursday and was observed post vaccination by trained nurses. He felt he was developing an allergic reaction and was allowed to self-administer his personal epi-pen. He was taken to the Emergency Department, evaluated, treated, observed and discharged.


Ray Jordan, a spokesperson from the biotechnology company, told CNN: "Moderna can't confirm the incident but reported the potential adverse event through its internal safety reporting system and Moderna is further investigating the incident."


It's still unknown what ingredient in the coronavirus vaccines may be causing severe allergic reactions in some people. Dr. Peter Marks, who heads the FDA's Center for Biologics Evaluation and Research, said in a briefing last week that the agency is investigating a compound known as polyethylene glycol (PEG), as well as four other possible ingredients in the formulation.


Pfizer CEO Albert Bourla explained in a town hall that adverse reactions to the vaccine were "very rare" in clinical trials. He pointed out that now that the vaccine is being distributed to millions of people, adverse events are inevitable. He added that these incidents should not keep people from taking the vaccine, especially those with preexisting conditions that put them at risk for severe Covid-19.  Moncef Slaoui, chief scientific adviser for Operation Warp Speed, said there are discussions between the vaccine makers and the National Institutes of Health to consider conducting clinical trials of Covid-19 vaccines in very allergic populations, such as those who have to carry an EpiPen with them at all times. He said a trial could help understand the rate of allergic reactions and what is provoking them.


Weekly Brief

loading
Towards a New World Order
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/covid19-vaccines-and-allergic-reactions-nwid-255.html